This article is more than 5 years old. Information may no longer be current.

AMO to buy Quest Vision

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA ANA, Calif. — Advanced Medical Optics has exercised an option to buy Quest Vision Technologies, a company whose accommodative IOL technology AMO was already licensing.

According to a press release, the accommodative IOL, being developed for the treatment of presbyopia “provides accommodation through changing the shape of the optic with or without axial movement.”

Quest Vision’s technology is “distinct from others under development in the industry because it uses the concept of a shape-changing optic to provide accommodation, rather than an axial movement used in single- or dual-optic alternatives,” said Jim Mazzo, AMO’s president and chief executive officer.

Financial terms of the agreement were not disclosed.